Skip To Main Content
Lorriana E. Leard on Muck Rack

Lorriana E. Leard

As seen in: Physician's Weekly, jhltonline.org, Respiratory Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lorriana E.

Contact Lorriana E., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Transformation of Transplant Medicine with Artificial Intelligence-Assisted Tacrolimus Dosing

|
By Lorriana E. Leard, Catherine Blebea
| jhltonline.org Verified
Abbreviations AI (artificial intelligence) LSTM (long short-term memory) Get full text access Log in, subscribe or purchase for full access. References 1. Choshi, H. ∙ Miyoshi, K. ∙ Tanioka, M. ... Long Short-Term Memory Algorithm for Personalized Tacrolimus Dosing: A Simple and Effective Time Series Forecasting Approach Post-Lung Transplantation J Heart Lung Transplant. 2024; Published online November 5 2. Basuli, D. ∙ Roy, S.
Open in Who Shared Issue with article?

A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant.

|
By Krishnan Warrior, Lorriana E. Leard, Arun Nair Verified, Cynthia J. Gries
| Physician's Weekly
Krishnan Warrior,Lorriana E Leard,Arun R Nair,Cynthia J Gries,Andrew J Fisher,Simon R Johnson,Francis X McCormack,Daniel F Dilling Krishnan Warrior Division of Pulmonary and Critical Care, Loyola University Health System, Stritch School of Medicine, USA. Lorriana E Leard Division of Pulmonary and Critical Care, Department of Medicine, University of California, San Francisco, USA.
Open in Who Shared Issue with article?
|
By Arun Nair Verified, Krishnan Warrior, Lorriana E. Leard, Andrew Fisher, Simon Johnson Verified, Francis X. McCormack, Daniel F Dilling, Krishnan Warrior, Lorriana E. Leard, Cynthia J. Gries
| Respiratory Medicine Verified
Highlights • Lymphangioleiomyomatosis is a rare indication for lung transplantation. • Use of mTOR inhibitors in LAM patients on the waiting list is controversial. • Our survey results suggest excellent outcomes in patients using mTOR inhibitor while on the waitlist. • Guidelines regarding use of mTOR inhibitors in LAM patients on the waitlist should be reconsidered. Abstract Background Lymphangioleiomyomatosis (LAM) is an uncommon indication for lung transplantation.
Open in Who Shared Issue with article?
See all 3 articles